Perception of Palliative Care and Prognostic Awareness of Lung Cancer Treatment in an Oncogene-Driven Lung Cancer Community

Project PRIORITY is a patient-founded and patient-driven research partnership between the EGFR Resisters and LUNGevity Foundation. This specific part of the study was presented as a poster in WCLC 2020 and focuses on palliative care and prognostic awareness perceptions.